Source The Lancet:
A new two-part Lancet Series on stem cells outlines exciting new advances in the treatment of multiple sclerosis and severe epidermolysis bullosa, a rare but devastating genetic skin disease. In the first Series paper, Professor Neil Scolding and colleagues, outline the latest challenges and exciting potential for stem cell treatment of multiple sclerosis. For more click here (please note there is an audio link on the bottom right of the screen where Prof Neil Scolding discusses the future role of stem-cell therapies for multiple sclerosis)
Each year we ask people who work at Milton Park to complete a survey to help us learn more about their ideas and what they think can be improved across the park. Changes you may have already noticed from previous survey are the new road signs, landscaping and a change in layout in Café Metro.
I ask you to kindly circulate this amongst your staff. All entries will be given the opportunity to enter our free prize draw to win some fabulous prizes including an Apple iPad mini, Amazon Kindle or new Apple iPod Nano.
A comprehensive response to this survey will provide useful feedback and aid us in understanding how best to serve you and your employees, thus ensuring the quality of life for occupiers and business efficiency is maintained at the highest level.
To complete this survey please click the link: www.miltonpark.co.uk/survey.
On Friday the 11th October MEPC will be having road resurfacing carried out on the road outside The Centre. Please ensure you do not park in these area’s or restrict access in any way.
The contractor carrying out the work will keep disruption to a minimum and access to area’s will be maintained although a certain amount of delay might be inevitable depending at what stage of the works that they are at.
Apologises for any inconvenience this may cause.
Source MS Society:
Results of a new study into finding the genes that may increase a person’s likelihood of developing MS have been published today (30th Sept) in the journal Nature Genetics. Read more here!